• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL ¿ L CONNECTOR C90J; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL ¿ L CONNECTOR C90J; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515309
Device Problems Leak/Splash (1354); Separation Problem (4043)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/17/2022
Event Type  malfunction  
Manufacturer Narrative
There were multiple potential lot numbers reported to be involved.The information for each additional lot number is as follows: medical device lot #: 2111212, medical device expiration date: 31oct2025, device manufacture date: 19nov2021; medical device lot #: 2111214, medical device expiration date: 31oct2025, device manufacture date: 23nov2021.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported while using bd phaseal ¿ l connector c90j the membrane separated and leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter, translated from japanese to english: this is a report about separation of the membrane of l-connector, resulting in chemo leakage.When the hcp disengaged the injector from the l-connector, the membrane was separated from the l-connector, resulting in leakage of the anticancer agent.
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes d10: returned to manufacturer on: 11sep2022.H6: investigation summary one sample was provided to our quality team for investigation.After visual inspection, it was observed that the membrane was never assembled onto the connector body, therefore the system was open and leaked when used.A device history review was performed for suspected lots 2111212, 2111214, and 2201207, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this issue.Five retained samples were used for additional evaluation.All product was visually inspected and verified the membranes were properly assembled.Assembly of the membrane is performed manually.A detection system is used to verify the proper welding and location of the membrane.All quality records verify the inspections were performed according to procedure.While we cannot identify a direct issue, it was determined this incident is due to the operator not properly welding the membrane onto the connector body and the detection system also not identifying/rejecting the impacted piece.A project was initiated to further address this issue and prevent any reoccurrence.Complaints received for this device and reported condition will continue to be tracked and trended for future occurrence.
 
Event Description
It was reported while using bd phaseal ¿ l connector c90j the membrane separated and leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter, translated from japanese to english: this is a report about separation of the membrane of l-connector, resulting in chemo leakage.When the hcp disengaged the injector from the l-connector, the membrane was separated from the l-connector, resulting in leakage of the anticancer agent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL ¿ L CONNECTOR C90J
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15407247
MDR Text Key306088745
Report Number3003152976-2022-00413
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number515309
Device Lot Number2201207
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/17/2022
Initial Date FDA Received09/12/2022
Supplement Dates Manufacturer Received10/20/2022
Supplement Dates FDA Received11/07/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-